Subscribe

Receive updates about our latest products in your inbox

Register For Our Next Webinar

The Truth About Collagen Supplementation

About Us

For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional

Search the Blog

  • There are no suggestions because the search field is empty.

Lower Levels of DHA and EPA Observed with ADHD

Child_writingIn a meta-analysis review of both randomized controlled trials (RCT) and case-control studies, the effects of omega-3 (n-3) polyunsaturated fatty acids (PUFAs) on both clinical symptoms and cognition in children and adolescent with ADHD was assessed. The RCT reviewed 534 youths with ADHD, supplemented with omega-3 polyunsaturated fatty acids. Improved clinical symptoms of ADHD (p<0.0001) was demonstrated in this group. In the three RCTs (n=214) ADHD diagnosed youths, supplemented with omega-3 polyunsaturated fatty acids were also demonstrated to “improve cognitive measures associated with attention (g=1.09, p=0.001)”. It was also observed that both children and adults diagnosed with ADHD had lower levels of n-3 PUFAs, “DHA (seven studies, n=412, g=−0.76, p=0.0002), EPA (seven studies, n=468, g=−0.38, p=0.0008), and total n-3 PUFAs (six studies, n=396, g=−0.58, p=0.0001).” It was concluded that n-3 PUFA supplementation “improve(d) clinical symptoms and cognitive performances in children and adolescents with ADHD,” and thus substantiates the use of omega-3 fatty acid in both of these groups with ADHD.

Chang J-C, Su K-P, Mondelli V, Pariante CM. Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies. Neuropsychopharmacology. (25 July 2017) | doi:10.1038/npp.2017.160.\r\nPublished online ahead of print.

 

Share This: 
 

Submit your comment

Related Post